Provided by Tiger Fintech (Singapore) Pte. Ltd.

Catabasis Pharmaceuticals

8.54
+0.0000
Volume:- -
Turnover:- -
Market Cap:109.52M
PE:-0.16
High:8.54
Open:8.54
Low:8.54
Close:8.54
Loading ...

Company Profile

Company Name:
Catabasis Pharmaceuticals
Exchange:
NASDAQ
Establishment Date:
- -
Employees:
- -
Office Location:
- -
Zip Code:
- -
Phone:
- -
Fax:
- -
Introduction:
Catabasis Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics in the United States. The company's lead product candidate is QLS-215, a monoclonal antibody inhibitor of plasma kallikrein that is in preclinical development for the treatment of hereditary angioedema, a rare, debilitating and potentially life-threatening disease. The company was incorporated in 2008 and is based in Boston, Massachusetts.